Stereotactic Body Radiotherapy as a Salvage Therapy after Incomplete Radiofrequency Ablation for Hepatocellular Carcinoma: A Retrospective Cohort Study

Stereotactic Body Radiotherapy as a Salvage Therapy after Incomplete Radiofrequency Ablation for Hepatocellular Carcinoma: A Retrospective Cohort Study

Residual tumor tissue after radiofrequency ablation (RFA) is inevitable in clinical practice, and the optimal management of residual tumor after RFA has not been established. To evaluate the efficiency and toxicity of stereotactic body radiotherapy (SBRT) as a salvage therapy after incomplete RFA fo...

Full description

Bibliographic Details
Main Authors:	Yizhen Fu, Mian Xi, Yangxun Pan, Jinbin Chen, Juncheng Wang, Shiliang Liu, Li Xu, Zhongguo Zhou, Mengzhong Liu, Minshan Chen, Lei Zhao, Yaojun Zhang
Format:	Article
Language:	English
Published:	Hindawi Limited 2020-01-01
Series:	Journal of Oncology
Online Access:	http://dx.doi.org/10.1155/2020/4835653

Similar Items

Stereotactic Body Radiotherapy as a Salvage Therapy after Incomplete Radiofrequency Ablation for Hepatocellular Carcinoma: A Retrospective Propensity Score Matching Study
by: Yang-Xun Pan, et al.
Published: (2019-08-01)

Tumor Location Influences Oncologic Outcomes of Hepatocellular Carcinoma Patients Undergoing Radiofrequency Ablation
by: Jinbin Chen, et al.
Published: (2018-10-01)

Stereotactic Body Radiotherapy vs. Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma: A Meta-Analysis
by: Yang-Xun Pan, et al.
Published: (2020-10-01)

Stereotactic body radiotherapy versus radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis
by: Lei Wang, et al.
Published: (2020-01-01)

Commentary: Stereotactic Body Radiotherapy vs. Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma: A Meta-Analysis
by: Zhaonan Li, et al.
Published: (2021-05-01)

Radiofrequency ablation versus stereotactic body radiotherapy for small hepatocellular carcinoma: a Markov model‐based analysis
by: Young‐Seok Seo, et al.
Published: (2016-11-01)

Stereotactic Radiofrequency Ablation of Liver Tumors in Octogenarians
by: Peter Schullian, et al.
Published: (2019-09-01)

Transarterial Chemoembolization Combined with Radiofrequency Ablation in the Treatment of Stage B1 Intermediate Hepatocellular Carcinoma
by: Furong Liu, et al.
Published: (2019-01-01)

Effective salvage of recurrent craniopharyngioma with fractionated stereotactic radiotherapy
by: Laura Burgess, et al.
Published: (2020-10-01)

Stereotactic radiofrequency ablation of subcardiac hepatocellular carcinoma: a case-control study
by: Peter Schullian, et al.
Published: (2019-01-01)

Advances in Radiobiology of Stereotactic Ablative Radiotherapy
by: Bin Qiu, et al.
Published: (2020-08-01)

Postoperative neutrophil-to-lymphocyte ratio change predicts survival of patients with small hepatocellular carcinoma undergoing radiofrequency ablation.
by: Jiaqiang Dan, et al.
Published: (2013-01-01)

Stereotactic radiofrequency ablation of a variety of liver masses in children
by: Benjamin Hetzer, et al.
Published: (2020-01-01)

Adrenal oligometastasis cured with stereotactic ablative radiotherapy
by: Julia Malone, BSC, et al.
Published: (2020-11-01)

The Confluence of Stereotactic Ablative Radiotherapy and Tumor Immunology
by: Steven Eric Finkelstein, et al.
Published: (2011-01-01)

Stereotactic Ablative Radiotherapy for Oligometastatic Disease in Liver
by: Myungsoo Kim, et al.
Published: (2014-01-01)

Survival and prognostic factors for patients with advanced hepatocellular carcinoma after stereotactic ablative radiotherapy.
by: Cheng-Hsiang Lo, et al.
Published: (2017-01-01)

Effectiveness of stereotactic ablative radiotherapy in patients with advanced hepatocellular carcinoma unsuitable for transarterial chemoembolization
by: Hsin-Lun Lee, et al.
Published: (2019-12-01)

Effect of prior cancer on survival of hepatocellular carcinoma: implications for clinical trial eligibility criteria
by: Xuqi Sun, et al.
Published: (2021-02-01)

Combination Therapy after TACE for Hepatocellular Carcinoma with Macroscopic Vascular Invasion: Stereotactic Body Radiotherapy versus Sorafenib
by: Lujun Shen, et al.
Published: (2018-12-01)

Organizing pneumonia after stereotactic ablative radiotherapy of the lung
by: Murai Taro, et al.
Published: (2012-08-01)

Stereotactic ablative radiotherapy for colorectal cancer liver metastasis
by: LI Xuemin
Published: (2021-03-01)

Feasibility of proton transmission-beam stereotactic ablative radiotherapy versus photon stereotactic ablative radiotherapy for lung tumors: a dosimetric and feasibility study.
by: Benjamin Mou, et al.
Published: (2014-01-01)

Safety and efficacy study: Short-term application of radiofrequency ablation and stereotactic body radiotherapy for Barcelona Clinical Liver Cancer stage 0-B1 hepatocellular carcinoma.
by: Feiqian Wang, et al.
Published: (2021-01-01)

Early Stage Non-small Cell Lung Cancer: Surgery or Stereotactic Ablative Radiotherapy?
by: Hui LIU
Published: (2015-06-01)

Ablative Radiotherapy in Prostate Cancer: Stereotactic Body Radiotherapy and High Dose Rate Brachytherapy
by: Ting Martin Ma, et al.
Published: (2020-12-01)

A feasibility study of stereotactic radiosurgery/stereotactic body radiotherapy/stereotactic ablative radiotherapy practice using tomoedge in helical tomotherapy for lung, liver, and spine targets
by: N V. N. Madhusudhana Sresty, et al.
Published: (2021-01-01)

Evolution of Stereotactic Ablative Radiotherapy in Lung Cancer and Birmingham’s (UK) Experience
by: Sundus Yahya, et al.
Published: (2018-07-01)

Stereotactic Ablative Radiotherapy for the Treatment of Clinically Localized Renal Cell Carcinoma
by: Scott P. Campbell, et al.
Published: (2015-01-01)

CyberKnife Stereotactic Ablative Radiotherapy for Recurrent or Oligometastatic Gynecological Cancers
by: Tejinder Kataria, et al.
Published: (2021-04-01)

Stereotactic ablative radiotherapy versus conventionally fractionated radiotherapy in the treatment of hepatocellular carcinoma with portal vein invasion: a retrospective analysis
by: Jen-Fu Yang, et al.
Published: (2019-10-01)

Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation
by: Hanbo Chen, et al.
Published: (2018-08-01)

Primary lung sarcoma treated with stereotactic ablative radiotherapy: a case report
by: Yeo SG
Published: (2017-07-01)

Establishing the Role of Stereotactic Ablative Body Radiotherapy in Early-Stage Breast Cancer
by: Aisling Barry, et al.
Published: (2018-01-01)

Renal atrophy following gated delivery of stereotactic ablative radiotherapy to adrenal metastases
by: John R. van Sörnsen de Koste, et al.
Published: (2021-10-01)

Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer
by: Kwon Jung, et al.
Published: (2010-09-01)

Comparing stereotactic ablative radiotherapy (SABR) versus re-trans-catheter arterial chemoembolization (re-TACE) for hepatocellular carcinoma patients who had incomplete response after initial TACE (TASABR): a randomized controlled trial
by: Liang-Cheng Chen, et al.
Published: (2019-03-01)

Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy
by: Liangrong Shi, et al.
Published: (2019-11-01)

Restricted bowel loop contouring: Improving efficiency in radiotherapy contouring for abdomino-pelvic Stereotactic Ablative Radiotherapy (SABR)
by: Eleanor Clarke, et al.
Published: (2020-09-01)

Efficacy of salvage stereotactic radiotherapy for recurrent glioma: impact of tumor morphology and method of target delineation on local control
by: Ogura, Kengo
Published: (2014)